Skip to main content

Table 1 Baseline characteristics

From: Cardiopulmonary exercise testing and impedance cardiography in the assessment of exercise capacity of patients with coronary artery disease early after myocardial revascularization

Variable

Study group (n = 54)

Men, n (%)

41 (75.9)

Age (years), mean ± SD

59.5 ± 8.6

SBP (mmHg), mean ± SD

133.4 ± 18.6

DBP (mmHg), mean ± SD

77.5 ± 11.1

HR (bpm), mean ± SD

66.8 ± 11.9

BMI (kg/m2), mean ± SD

28.3 ± 4.1

Creatinine (mg/dL), mean ± SD

0.92 ± 0.20

eGFR < 60 mL/min/1.73 m2, n (%)

3 (5.6)

LVEF (%), mean ± SD

54.5 ± 7.8

LVEF < 50%,, n (%)

11 (20.4)

HFpEF, n (%)

3 (5.6)

HFmrEF, n (%)

4 (7.4)

HFrEF, n (%)

5 (9.3)

Hypertension, n (%)

39 (72.2)

Diabetes, n (%)

11 (20.4)

hypercholesterolemia, n (%)

45 (83.3)

COPD, n (%)

3 (5.6)

Atrial fibrillation paroxysmal in medical history, n (%)

5 (9.3)/0 (0.0)

Smoking, n (%)

29 (53.7)

Symptoms

 Reduced exercise tolerance, n (%)

25 (46.5)

 Dyspnea during exercise, n (%)

14 (25.9)

 Dyspnea at rest, n (%)

3 (5.6)

Pharmacotherapy

 ACEI, n (%)

53 (98.2)

 ARB, n (%)

1 (1.9)

 BB, n (%)

51 (94.4)

 Diuretic, n (%)

20 (37.0)

 CB, n (%)

11 (20.4)

 MRA, n (%)

3 (5.6)

 Statin, n (%)

53 (98.2)

 Antiplatelet, n (%)

54 (100)

  1. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BB beta bloker, BMI body mass index, CB calcium canal blocker, COPD chronic obstructive pulmonary disease, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, HFmrEF heart failure with a mid-range ejection fraction, HFpEF heart failure with preserved ejection fraction, HFrEF heart failure with a reduced ejection fraction, HR heart rate, LVEF left ventricular ejection fraction, LVH left ventricular hypertrophy, MRA mineralocorticoid receptor antagonists, SBP systolic blood pressure, SD standard deviation